| 000 | 01454 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517082416.0 | ||
| 264 | 0 | _c20161213 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1573-7217 | ||
| 024 | 7 |
_a10.1007/s10549-016-3729-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTurturro, Sanja B | |
| 245 | 0 | 0 |
_aMutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin. _h[electronic resource] |
| 260 |
_bBreast cancer research and treatment _cFeb 2016 |
||
| 300 |
_a33-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAspirin _xpharmacology |
| 650 | 0 | 4 |
_aBreast Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aClass I Phosphatidylinositol 3-Kinases |
| 650 | 0 | 4 |
_aCytostatic Agents _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 beta _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMCF-7 Cells |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xgenetics |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins p21(ras) _xgenetics |
| 700 | 1 | _aNajor, Matthew S | |
| 700 | 1 | _aRuby, Carl E | |
| 700 | 1 | _aCobleigh, Melody A | |
| 700 | 1 | _aAbukhdeir, Abde M | |
| 773 | 0 |
_tBreast cancer research and treatment _gvol. 156 _gno. 1 _gp. 33-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10549-016-3729-8 _zAvailable from publisher's website |
| 999 |
_c25769685 _d25769685 |
||